Relevant conflicts of interest/financial disclosures Nothing to declare. Full financial disclosures and author roles may be found in the online version of this article.
Pramipexole versus ropinirole: Polysomnographic acute effects in restless legs syndrome†
Version of Record online: 2 MAR 2011
Copyright © 2011 Movement Disorder Society
Volume 26, Issue 5, pages 892–895, April 2011
How to Cite
Manconi, M., Ferri, R., Zucconi, M., Oldani, A., Giarolli, L., Bottasini, V. and Ferini-Strambi, L. (2011), Pramipexole versus ropinirole: Polysomnographic acute effects in restless legs syndrome. Mov. Disord., 26: 892–895. doi: 10.1002/mds.23543
- Issue online: 21 APR 2011
- Version of Record online: 2 MAR 2011
- Manuscript Accepted: 18 OCT 2010
- Manuscript Revised: 7 OCT 2010
- Manuscript Received: 28 JUN 2010
Additional Supporting Information may be found in the online version of this article.
|MDS_23543_sm_authorroles.doc||20K||Author Roles and Disclosures|
|MDS_23543_sm_suppinfo.doc||98K||E-Table 1. Comparison between the LM activity parameters and VAS obtained at baseline in the 3 groups of RLS patients included in this study.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.